论文信息 - Phase II Study of Celecoxib and Docetaxel in Non-small Cell Lung Cancer (NSCLC) Patients with Progression after Platinum-Based Therapy - 字舞流文

Phase II Study of Celecoxib and Docetaxel in Non-small Cell Lung Cancer (NSCLC) Patients with Progression after Platinum-Based Therapy

A. Wozniak | S. Gadgeel | G. Kalemkerian | F. Worden | Wei Chen | B. Schneider | M. Kraut | Daryn W. Smith | Daryn Smith